Skip to main content

ROCKWELL MEDICAL INC

For the period ended Mar 31, 2025. Filed May 12, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 12, 2025

RMTI$7.73+1.7%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Cover page

Show cover page

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2025

or

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number:000-23661

ROCKWELL MEDICAL, INC.

(Exact name of registrant as specified in its charter)

Delaware38-3317208
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
30142 S. Wixom Road, Wixom, Michigan48393
(Address of principal executive offices)(Zip Code)

(248)960-9009

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer☐Accelerated filer☐
Non-accelerated filer☒Smaller reporting company☒
Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).☐ Yes☒No

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:Trading SymbolName of each exchange on which registered:
Common Stock, par value $0.0001RMTINasdaq Capital Market

The number of shares of common stock outstanding as of May 6, 2025 was 34,174,687.

Rockwell Medical, Inc. and Subsidiaries

Index to Form 10-Q

Page
Part I — Financial Information (unaudited)
Item 1 - Unaudited Financial Statements
Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 20243
Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2025 and 20245
Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2025 and 20246
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended March 31, 2025 and 20247
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2025 and 20248
Notes to Condensed Consolidated Financial Statements9
Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations18
Item 3 - Quantitative and Qualitative Disclosures about Market Risk19
Item 4 - Controls and Procedures19
Part II — Other Information
Item 1 - Legal Proceedings19
Item 1A - Risk Factors19
Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds19
Item 3 - Defaults Upon Senior Securities19
Item 4 - Mine Safety Disclosures19
Item 5 - Other Information19
Item 6 - Exhibits19
Signatures20
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.